Anticancer research · 2014
A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cinar Pelin, Calkins Sarah M, Venook Alan P, Kelley Robin K
Аннотация
BACKGROUND: Overexpression of the human epidermal growth factor 2 (HER2) is associated with an aggressive metastatic phenotype in patients with breast cancer but its prognostic impact is not well-characterized in gastroesophageal adenocarcinoma.
PATIENTS AND METHODS: This is a retrospective series of three cases of HER2-positive gastroesophageal cancer.
RESULTS: In this case series, we describe three patients presenting with widespread metastatic disease prior to development of symptoms from the primary tumor. Two patients presented with brain metastases, while one demonstrated lymphangitic spread to lungs.
CONCLUSION: Pooled analyses of outcomes among sub-populations of contemporary trials are needed to better understand the natural history and prognostic impact of HER2 over-expression in patients with gastroesophageal cancers.
PATIENTS AND METHODS: This is a retrospective series of three cases of HER2-positive gastroesophageal cancer.
RESULTS: In this case series, we describe three patients presenting with widespread metastatic disease prior to development of symptoms from the primary tumor. Two patients presented with brain metastases, while one demonstrated lymphangitic spread to lungs.
CONCLUSION: Pooled analyses of outcomes among sub-populations of contemporary trials are needed to better understand the natural history and prognostic impact of HER2 over-expression in patients with gastroesophageal cancers.
Предметные рубрики MeSH
AdenocarcinomaAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBrain NeoplasmsCamptothecinCapecitabineCarboplatinDeoxycytidineEsophageal NeoplasmsEsophagogastric JunctionFluorouracilHumansIrinotecanLung NeoplasmsLymphatic MetastasisMaleMiddle AgedErb-b2 Receptor Tyrosine KinasesRetrospective StudiesStomach NeoplasmsTrastuzumab